Boehringer Ingelheim has appointed Yew Looi Liew (YL) President of U.S. Human Pharma at its U.S. headquarters. In his new role, Mr. Liew is responsible for ensuring the successful development of the current human pharma portfolio and preparing the organization for future launches.
“I am energized by the passion YL brings to Boehringer Ingelheim every day to help transform the lives of patients,” said Jean-Michel Boers, President & CEO, and U.S. Country Managing Director, Boehringer Ingelheim USA Corporation.